F&N 1-7

03/08

 

Abstract

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention

 

Prepared by:   Janice Hermann, Ph.D., R.D./L.D.

                        Nutrition Education Specialist

301 HES/NSCI

                        Cooperative Extension Service

                        Stillwater, OK 74078-6111

                        (405) 744-4601

 

Sources:

NIH State-of-the Science Panel J Am Clin Nutr. 2007;85(suppl): 257S-264S.

 


IMPLICATIONS FOR COOPERATIVE EXTENSION. Use of multivitamin/multimineral supplements has rapidly grown over the past several decades. Dietary supplements are now used by more than half of the adult population. In general, dietary supplements are used by individuals who practice healthier lifestyles, thus making evaluation of the relationship between supplement use and health outcomes difficult to interpret.

 

Despite extensive dietary supplement use, there is still insufficient knowledge about the actual amount of total nutrients Americans consume from diet and supplements. This is in part due to fortification of foods with nutrients, which adds to the effects of dietary supplements. Historically, food fortification led to the decline of nutrient deficiencies, but cumulative effects of supplementation and fortification have also raised safety concerns related to exceeding upper levels. Thus, there is a need obtain accurate and current information on the public's total intake of nutrients in foods and dietary supplements.

There are few rigorous studies to determine clear recommendations regarding the safety and effectiveness of dietary supplements in relationship to chronic disease prevention. Most of studies do not provide strong evidence for health benefits effects of supplements. However, within some studies or population subgroups, there is encouraging evidence of health benefits. However, several other studies also provide disturbing evidence of risk.

The current level of public assurance of dietary supplement safety and quality is inadequate, given the fact that manufacturers are not required to report adverse events and FDA has no regulatory authority to require labeling changes or to help inform the public of these issues and concerns. It is important that FDA purview of these products be authorized and implemented.

In conclusion, at the present time, evidence is insufficient either for or against the use of dietary supplements to prevent chronic disease. Resolution of this issue will require advances in research and improved communication and collaboration between scientists, health care providers, pharmaceutical industries, supplement industries, and the public.